LEXX
Lexaria Bioscience Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.70
+0.02 ▲ +3.12%
🌙 3월 13일 7:36 PM ET (한국 3/14 08:36)
$0.72
+0.02 ▲ +2.86%
| Index | - | P/E | - | EPS (ttm) | -0.57 | Insider Own | 5.36% | Shs Outstand | 0.02B | Perf Week | -15.54% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | 13.89% | Insider Trans | - | Shs Float | 0.02B | Perf Month | 9.79% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.1 | Inst Own | 6.84% | Short Float | 1.63% | Perf Quarter | -39.66% |
| Income | -0.01B | P/S | 33.5 | EPS this Y | 45.45% | Inst Trans | -0.1% | Short Ratio | 0.61 | Perf Half Y | -34.58% |
| Sales | 0.00B | P/B | 3.17 | EPS next 5Y | 24.86% | ROA | -136.24% | Short Interest | 0.38M | Perf YTD | 13.45% |
| Book/sh | 0.22 | P/C | 3.94 | EPS past 3/5Y | 18.8% 14.15% | ROE | -146.97% | 52W High | -63.07% ($1.90) | Perf Year | -46.97% |
| Cash/sh | 0.18 | P/FCF | - | Sales past 3/5Y | 40.34% 17.53% | ROIC | -216.57% | 52W Low | 52.17% ($0.46) | Perf 3Y | -76.43% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -17.41% | Gross Margin | 84.9% | Volatility(W/M) | 13.42% 11.61% | Perf 5Y | -88.99% |
| Dividend TTM | - | EV/Sales | 24.44 | Sales Y/Y TTM | 5.05% | Oper. Margin | -2021.04% | ATR (14) | 0.08 | Perf 10Y | -82.05% |
| Dividend Ex-Date | - | Quick Ratio | 3.68 | EPS Q/Q | 54.01% | Profit Margin | -2067.65% | RSI (14) | 48.52 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.68 | Sales Q/Q | -100% | SMA20 | 0.98% ($0.69) | Beta | 0.56 | Target Price | $3.75 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2026/01/21 | SMA50 | -2.6% ($0.72) | Rel Volume | 0.13 | Prev Close | $0.68 |
| Employees | 7 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 23.08% -50% | SMA200 | -22.29% ($0.9) | Avg Volume(3M) | 0.63M | Price | $0.7 |
| IPO | 2006/10/10 | Option/Short | No/Yes | Trades | 270 | Volume | 82,897 | Change | 3.12% |
뉴스 로딩 중...